You, our members, are at the heart of everything we do. This next step is no different. The decision to explore a merger with HESTA is about securing your financial future and continuing to provide a strong and sustainable future for our members.
Mercy Super has a long and proud 60-year history of supporting our members from Mater’s South Brisbane hospital campus. We’ve always put the interest of our members first and believe it is now time for our members to benefit from being part of a larger fund.
We conducted analysis of relevant funds matching our criteria for scale and delivery of improved member outcomes. From this analysis, we chose to enter into exclusive discussions with HESTA due to its strong track record of performance, future sustainability and deep links to the health sector.
1. Source: SuperRatings SR50 (60-76) Index at superratings.com.au. Past performance is not indicative of future performance. 2. Source: https://www.apra.gov.au/annual-fund-level-superannuation-statistic
While some things may change with this merger, our plan is to keep many of our key differences that are valued by our members. This includes:
The plan is for your investment options to be matched to the most suitable HESTA options and the administration fees and costs will be the same that applies to HESTA members.
Full details of how this will work will become clearer as both parties work through the implementation plan. We’ll keep you informed and provide plenty of notice if and when changes may affect your account
While we’re in the due diligence and legal phase exploring the benefits of a merger with HESTA, nothing changes with your Mercy Super account and there is nothing you need to do. It is business as usual for Mercy Super members.
We’ll keep you up to date with progress on the merger as details evolve.
Whatever the question, we’re here to help. Jump on the phone, send an email or if you happen to be near Mater’s South Brisbane campus – drop in and see us.
We’d love to catch up and help you get the most out of your super.